Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps  Latest publication
2-(2,3-Dihydro-1H-indol-1-ylcarbonyl)-N-(3-methylphenyl)quinazolin-4-amine
Potential treatment - theoretical effect Experimental Antiviral Dec/04/2020
SARS-CoV-2-IN-1
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/09/2020
S2X259
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
Capreomycin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021
Aloxistatin
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/27/2021
Clofazimine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/07/2021
S2K146
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/06/2022
Yindan Jiedu
Potential treatment - clinical evidence Natural product Antiviral Feb/05/2021
Dalbavancin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/01/2020
S2N28
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
Dihydromyricetin
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/04/2021
Estradiol
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/19/2021
Gallic acid
Potential treatment - theoretical effect Natural product Antiviral Jan/06/2021
Favipiravir
Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021
Stenoparib
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/19/2021
Caerin 1.10
Potential treatment - theoretical effect Natural product Antiviral Nov/25/2020
Camostat mesylate
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021
Ipomoeassin F
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/19/2021
Ombitasvir
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021
Sofosbuvir
Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/18/2020